Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations are in order for Senior Postdoctoral Research Scientist Dr Joaquim Miguel Vieira, who was been awarded an Intermediate Fellowship from the British Heart Foundation. This award will fund research designed to better understand the basic mechanisms behind cardiovascular development and could pave the way for innovative treatments of heart disease.

Joey VieiraDr Joaquim Vieira, a Senior Postdoctoral Research Scientist in Professor Paul Riley’s team, has been awarded a BHF Intermediate Basic Science Research Fellowship for his research “Investigating the functional role of the noncoding genome during epithelial-to-mesenchymal transition to enable cardiovascular regeneration." 

A heart attack occurs when blood flow to a large portion of the heart decreases or stops, causing damage to the heart muscle. Nearly one billion of muscle cells are permanently lost after such event and replaced by non-contractile scar tissue in a process called fibrosis that further compromises the function of the heart and ultimately, leads to heart failure. To date, no treatment has been effective in mending the heart following a heart attack.

In recent work here at DPAG, Dr Vieira has demonstrated that the heart attempts to replenish its damaged tissue by reverting to similar processes that were used in the embryo to build the heart before birth:

 

In particular, cells from the outer layer of the heart, the epicardium, become activated in a process called epithelial-to-mesenchymal transition (EMT), but this activation is transient and insufficient to support new blood vessel and muscle growth as it happens in the embryo, instead activated epicardial cells in the adult heart support the process of fibrosis. I propose that understanding the process of EMT in greater detail will enable the development of better drugs to stimulate the heart to repair itself more efficiently after a heart attack - Dr Joaquim Vieira

The award from the BHF will fund a five-year basic science project designed to functionally explore the yet poorly understood role of non-coding RNAs in the regulation of epithelial-to-mesenchymal transition (EMT) during heart development.

The aim is to achieve a better understanding of EMT and its regulatory mechanisms to enable novel therapeutic approaches for heart disease.

I am very grateful to the British Heart Foundation for sponsoring me for the next five years. This is an exciting opportunity for developing my research on understanding the basic cellular and molecular mechanisms regulating cardiovascular development, as an independent scientist working in a world-class environment. It is my belief that the knowledge arising from this study will enable the development of innovative and effective treatments for cardiovascular disease - Dr Joaquim Vieira

More information on the BHF Intermediate Basic Science Fellowship is available here.

Similar stories

Sherrington Talks 2021 Prize Winners

The 2021 Sherrington talks were presented by graduate students in their third year of DPhil research study.

Iron deficiency anaemia in early pregnancy increases risk of heart defects, suggests new research

In animal models, iron deficient mothers have a greatly increased risk of having offspring with congenital heart disease (CHD). The risk of CHD can be greatly reduced if the mother is given iron supplements very early in pregnancy. Additionally, embryos from a mouse model of Down Syndrome were particularly vulnerable to the effects of maternal iron deficiency, leading to a higher risk of developing severe heart defects.

Nicola Smart to deliver John French Lecture

The British Atherosclerosis Society's John French Memorial Lecture is named in honour of the Oxford-based pathologist, Dr John French, who made seminal observations and contributions to the field of cardiovascular pathology.

Celebrating the Women of DPAG

To mark the centenary of women being awarded degrees at Oxford University, DPAG celebrates some of the women who have contributed to the success of the Department, and its predecessor departments, over the last century

New target to develop immunosuppressants

A new study from the Parekh Group has resolved a long-standing question in our understanding of intracellular Ca2+ signalling, namely how a specific type of Ca2+ channel is uniquely able to signal to the nucleus to regulate gene expression. By unravelling this mechanism, researchers have identified a new approach for developing immunosuppressant drugs.